Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 35 holding rows worth $2,054,021,000.

Accession
0001654954-17-007453
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 35 entries on the cover page, a total value of $2,054,021,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,054,021,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,000,000$241,800,000thousands by filing dateput
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR5,266,450$174,951,000thousands by filing date
MYLAN NVN59465109SHS EURO4,245,889$164,825,000thousands by filing date
Gilead Sciences,Inc.375558103COM2,000,000$141,560,000thousands by filing date
Gilead Sciences,Inc.375558103COM2,000,000$141,560,000thousands by filing datecall
NEKTAR THERAPEUTICS640268108COM5,350,000$104,593,000thousands by filing date
ALLERGAN PLCG0177J108SHS350,000$85,082,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM2,458,100$80,011,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM5,400,000$79,434,000thousands by filing date
MYRIAD GENETICS INC62855J104COM3,000,000$77,520,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock4,000,000$77,360,000thousands by filing date
SELECT MED HLDGS CORP81619Q105COM5,000,000$76,750,000thousands by filing date
BIOVERATIV INC09075E100COM1,174,300$70,658,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM1,500,000$69,720,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM350,000$45,105,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM1,300,000$43,823,000thousands by filing date
ENDO INTL PLCG30401106SHS3,574,000$39,922,000thousands by filing date
ENDOLOGIX INC29266S106COM7,500,000$36,450,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,000,000$33,220,000thousands by filing datecall
AMAG PHARMACEUTICALS INC00163U106COM1,700,000$31,280,000thousands by filing date
BIOSCRIP INC09069N108COM10,180,000$27,639,000thousands by filing date
BIOGEN INC COM09062X103Stock100,000$27,136,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD2,347,593$25,706,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM200,000$24,334,000thousands by filing date
AXOVANT SCIENCES LTDG0750W104COM1,000,000$23,190,000thousands by filing date
INVITAE CORP46185L103COM2,398,123$22,926,000thousands by filing date
ENVISION HEALTHCARE CORP29414D100COM350,000$21,935,000thousands by filing date
AVEXIS INC05366U100COM210,000$17,254,000thousands by filing date
RITEAID CORP767754104COM5,000,000$14,750,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM500,000$9,165,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock535,500$7,497,000thousands by filing date
ARENA PHARMECEUTICALS INC040047102COMMON STOCK425,000$7,170,000thousands by filing date
BIOLASE INC090911108COMMON STOCK5,332,394$5,172,000thousands by filing date
RADIUS HEALTH INC750469207COM NEW100,000$4,523,000thousands by filing date
BIOLASE INC090911108COMMON STOCK1,841,173$0thousands by filing datecallValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001654954-17-007453this filing2017-08-14acceptance time not in the bulk data set